Stephen L Sabba is Director of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 30,178 shares of LGND, which is worth approximately $3.53 Million. The most recent transaction as insider was on Jun 14, 2024, when has been sold 1,252 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.2K
0% 3M change
12.08% 12M change
Total Value Held $3.53 Million

Stephen L Sabba Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2024
BUY
Grant, award, or other acquisition
-
1,252 Added 3.98%
30,178 Common Stock
Mar 05 2024
SELL
Open market or private sale
$140,649 $74.3 p/Share
1,893 Reduced 6.14%
28,926 Common Stock
Mar 05 2024
BUY
Exercise of conversion of derivative security
-
2,893 Added 8.58%
30,819 Common Stock
Jun 09 2023
BUY
Grant, award, or other acquisition
-
1,142 Added 4.07%
26,926 Common Stock
May 10 2023
SELL
Open market or private sale
$494,249 $77.13 p/Share
6,408 Reduced 19.91%
25,784 Common Stock
May 10 2023
BUY
Exercise of conversion of derivative security
-
6,408 Added 16.6%
32,192 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
1,004 Added 3.71%
26,065 Common Stock
Jun 04 2021
BUY
Grant, award, or other acquisition
-
630 Added 2.45%
25,061 Common Stock
Feb 09 2021
SELL
Open market or private sale
$3,055,468 $208.28 p/Share
14,670 Reduced 37.52%
24,431 Common Stock
Feb 09 2021
BUY
Exercise of conversion of derivative security
$166,211 $11.33 p/Share
14,670 Added 27.28%
39,101 Common Stock
SLS

Stephen L Sabba

Director
Syosset, NY

Track Institutional and Insider Activities on LGND

Follow LIGAND PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

News

Receive news related to LIGAND PHARMACEUTICALS INC

Track Activities on LGND